SECENDS - IBM

2025

Q4 3 filings

Oct

Q3 2025 Results

Financial data not available in provided content

10-Q

Oct

Q3 2025 Earnings

CEO Arvind Krishna and CFO Jim Kavanaugh Q3 earnings presentation

8-K

Oct

Q3 2025 Earnings

Financial results for period ended September 30, 2025

8-K

Q3 3 filings

Jul

Q2 2025 Results

Unable to extract specific revenue and EPS figures from provided XBRL metadata

10-Q

Jul

Q2 2025 Earnings

Earnings presentation materials disclosed

8-K

Jul

Q2 2025 Earnings

Q2 2025 financial results for period ended June 30, 2025

8-K

Q2 6 filings

Jun

Credit Facility Extensions

$10B total credit facilities extended: $2.5B to 2028, $7.5B to 2030

8-K

May

Annual Shareholder Meeting

13 directors elected, Say on Pay approved 92.0%

8-K

Apr

Dividend Increase

Quarterly dividend raised to $1.68 per share, 30th consecutive year of increases

8-K

Apr

Q1 2025 Results

Unable to extract specific revenue and EPS figures from provided XBRL data

10-Q

Apr

Q1 2025 Earnings

First quarter 2025 earnings presentation by CEO Arvind Krishna and CFO Jim Kavanaugh on April 23, 2025

8-K

Apr

Q1 Earnings

Q1 2025 financial results for period ended March 31, 2025

8-K

Q1 7 filings

Mar

Revenue Category Changes

Software and Consulting segments revenue categories restructured Q1 2025

8-K

Mar

2025 Proxy Statement

Annual Meeting: April 29, 2025 (virtual), 13 directors up for election, PwC as auditor

DEF 14A

Feb

FY2024 Results

Unable to extract specific revenue and EPS figures from provided XBRL taxonomy data

📌 Unable to identify specific milestone from provided XBRL taxonomy structure

10-K

Feb

Debt Offering

€3.5B Euro notes + $4.75B USD notes issued

8-K

Feb

Investor Day Presentation

CEO Arvind Krishna and CFO Jim Kavanaugh hosted investor day with strategy materials

8-K

Jan

Q4 2024 Earnings

Earnings presentation by CEO Arvind Krishna and CFO Jim Kavanaugh on Jan 29, 2025

8-K

Jan

Q4 2024 Earnings

Financial results for periods ended December 31, 2024

8-K

2024

Q4 4 filings

Dec

Investor Day Announcement

Feb 4, 2025 investor day in NYC at 1PM ET

8-K

Oct

Q3 2024 Results

Unable to extract specific revenue and EPS figures from provided XBRL metadata

10-Q

Oct

Q3 2024 Earnings

Q3 2024 earnings presentation materials disclosed

8-K

Oct

Q3 2024 Earnings

Financial results for period ended September 30, 2024

8-K

Q3 4 filings

Sep

Pension Risk Transfer

$6B pension obligations transferred, $2.7B settlement charge

8-K

Jul

Q2 2024 Results

Unable to extract specific revenue and EPS figures from provided XBRL format

10-Q

Jul

Q2 2024 Earnings

Earnings presentation materials filed for Q2 2024 results

8-K

Jul

Q2 2024 Earnings

Financial results for period ended June 30, 2024

8-K

Q2 3 filings

Jun

Credit Facility Extensions

$2.5B 3-year facility extended to 2027, $7.5B 5-year facility extended to 2029

8-K

May

Annual Shareholder Meeting

13 directors elected, say-on-pay approved 92.2%, all shareholder proposals rejected

8-K

Apr

Q1 2024 Results

Unable to extract specific revenue and EPS figures from provided XBRL data format

10-Q